Literature DB >> 15870834

Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men.

Jack H Mendelson1, Michelle B Sholar, Nathalie Goletiani, Arthur J Siegel, Nancy K Mello.   

Abstract

The acute effects of smoking a low- or high-nicotine cigarette on hypothalamic-pituitary-adrenal (HPA) hormones, subjective responses, and cardiovascular measures were studied in 20 healthy men who met American Psychiatric Association Diagnostic and Statistical Manual IV criteria for nicotine dependence. Within four puffs (or 2 min) after cigarette smoking began, plasma nicotine levels and heart rate increased significantly (P<0.01), and peak ratings of 'high' and 'rush' on a Visual Analogue Scale were reported. Reports of 'high', 'rush', and 'liking' and reduction of 'craving' were significantly greater after smoking a high-nicotine cigarette than a low-nicotine cigarette (P<0.05). Peak plasma nicotine levels after high-nicotine cigarette smoking (23.9+/-2.6 ng/ml) were significantly greater than after low-nicotine cigarette smoking (3.63+/-0.59 ng/ml) (P<0.001). After smoking a low-nicotine cigarette, adrenocorticotropin hormone (ACTH), cortisol, dehydroepiandrosterone (DHEA), and epinephrine did not change significantly from baseline. After high-nicotine cigarette smoking began, plasma ACTH levels increased significantly above baseline within 12 min and reached peak levels of 21.88+/-5.34 pmol/l within 20 min. ACTH increases were significantly correlated with increases in plasma nicotine (r=0.85; P<0.0001), DHEA (r=0.66; P=0.002), and epinephrine (r=0.86; P<0.0001). Cortisol and DHEA increased significantly within 20 min (P<0.05) and reached peak levels of 424+/-48 and 21.13+/-2.55 ng/ml within 60 and 30 min, respectively. Thus cigarette smoking produced nicotine dose-related effects on HPA hormones and subjective and cardiovascular measures. These data suggest that activation of the HPA axis may contribute to the abuse-related effects of cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870834      PMCID: PMC1383570          DOI: 10.1038/sj.npp.1300753

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  84 in total

1.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

Authors:  K E Habib; K P Weld; K C Rice; J Pushkas; M Champoux; S Listwak; E L Webster; A J Atkinson; J Schulkin; C Contoreggi; G P Chrousos; S M McCann; S J Suomi; J D Higley; P W Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Placebo cigarettes in smoking research.

Authors:  M L Robinson; E J Houtsmuller; E T Moolchan; W B Pickworth
Journal:  Exp Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.157

3.  Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry.

Authors:  P Jacob; S Wu; L Yu; N L Benowitz
Journal:  J Pharm Biomed Anal       Date:  2000-09       Impact factor: 3.935

4.  Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats.

Authors:  N E Goeders; G F Guerin
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

5.  Nicotine self-administration in rats on a progressive ratio schedule of reinforcement.

Authors:  E C Donny; A R Caggiula; M M Mielke; S Booth; M A Gharib; A Hoffman; V Maldovan; C Shupenko; S E McCallum
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

6.  Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: a behavioral economic analysis.

Authors:  T A Shahan; W K Bickel; G J Madden; G J Badger
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

7.  Effects of cocaine self-administration on plasma corticosterone and prolactin in rats.

Authors:  J R Mantsch; S D Schlussman; A Ho; M J Kreek
Journal:  J Pharmacol Exp Ther       Date:  2000-07       Impact factor: 4.030

8.  Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.

Authors:  Y Fu; S G Matta; W Gao; V G Brower; B M Sharp
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

9.  Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.

Authors:  M R Gerasimov; M Franceschi; N D Volkow; O Rice; W K Schiffer; S L Dewey
Journal:  Synapse       Date:  2000-12-15       Impact factor: 2.562

10.  Controlled dosing of nicotine via an Intranasal Nicotine Aerosol Delivery Device (INADD).

Authors:  O F Pomerleau; K A Flessland; C S Pomerleau; M Hariharan
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  57 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

2.  Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system.

Authors:  Jessica M McKlveen; Jared M Wilson; Robert T Rubin; Michael E Rhodes
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-01       Impact factor: 1.950

3.  Long lasting effects of smoking: breast cancer survivors' inflammatory responses to acute stress differ by smoking history.

Authors:  Jeanette M Bennett; Ronald Glaser; Rebecca R Andridge; Juan Peng; William B Malarkey; Janice K Kiecolt-Glaser
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

4.  Investigating the Effects of Exposure to Waterpipe Smoke on Pregnancy Outcomes Using an Animal Model.

Authors:  Omar F Khabour; Karem H Alzoubi; Nihaya Al-Sheyab; Alan Shihadeh; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2015-12-17       Impact factor: 4.244

5.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

6.  Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design.

Authors:  William L Kelemen; Farnaz Kaighobadi
Journal:  Exp Clin Psychopharmacol       Date:  2007-02       Impact factor: 3.157

7.  Effects of cigarette smoking and family history of alcoholism on sweet taste perception and food cravings in women.

Authors:  Marta Yanina Pepino; Julie A Mennella
Journal:  Alcohol Clin Exp Res       Date:  2007-11       Impact factor: 3.455

Review 8.  Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research.

Authors:  Rachel L Derr; Scott J Cameron; Sherita Hill Golden
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 9.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

Review 10.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.